| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dexibuprofen | apoptosis regulator bcl-2 | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | negative modulator |
| dexibuprofen | cystic fibrosis transmembrane conductance regulator | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| dexibuprofen | fatty acid-binding protein, intestinal | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | binder |
| dexibuprofen | platelet glycoprotein ib alpha chain | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| dexibuprofen | tissue-type plasminogen activator | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | modulator |
| dexibuprofen | peroxisome proliferator-activated receptor alpha | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| dexibuprofen | peroxisome proliferator-activated receptor gamma | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | activator |
| dexibuprofen | prostaglandin g/h synthase 1 | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | inhibitor |
| dexibuprofen | prostaglandin g/h synthase 2 | small molecule | NA | drugbank , DGIDB | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.08 | approved,investigational | inhibitor |
| dexibuprofen | protein s100-a7 | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| dexibuprofen | solute carrier family 15 member 1 | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| dexibuprofen | thrombomodulin | small molecule | NA | drugbank | Ankylosing spondylitis[MeSHID:D013167] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | modulator |
| click here to return to the previous page | ||||||||